The gentlebirth.org website is provided courtesy of
Ronnie Falcao, LM MS,
a homebirth midwife in Mountain View, CA
The gentlebirth.org website is provided courtesy of
Ronnie Falcao, LM MS,
a homebirth midwife in Mountain View, CA
|
I just had my mind expanded this morning by Laureen Hudson's hour long online session on how to use the internet to get a message out. Laureen's session “Creating an Online Presence," gave me a wealth of information in a short time and impressed me with how many people are out there who completely rely on the internet for their information. I needed that, and maybe you do, too. - Ina May Gaskin I just hung up the phone from doing the hour long session with
Laureen Hudson on “Creating an Online Presence”. Laureen’s know-how
and expertise were enough to wake up even the birth oldtimers like me and
Ina May to the many unused opportunities of the internet. Laureen’s
engaging and easygoing teaching style made even those scary (to me) terms
like “hypertext, streaming, wordpress, technorati, feedreader and trackback”
start to make sense. Her passion is to reach the generation of young
women who have not yet given birth BEFORE they fall into the black hole
of aggressive obstetrics. I came away from the class today with lots
of ways to improve my website and make it more modern, usable and interesting
for readers. This class will run again this coming Friday (August
22) and I heartily recommend it.
Cost: $35 per session Each session will be 60 minutes in length Creating An Online Presence
Search!
|
From C-ap@clari.net Tue Sep 26 15:24:31 PDT 1995 Keywords: Tokos Medical Corp, tick=TKOS, Business, MedicalWASHINGTON (AP) -- The Food and Drug Administration has approved the first blood test to indicate whether a pregnant woman is about to experience preterm labor.
The test, which the FDA approved last week, detects a protein called fetal fibronectin in women who are experiencing early symptoms of preterm labor, such as backache or cramps.
After the 20th week of pregnancy, fibronectin is not supposed to be detectable in the mother's blood unless there is a problem, such as preterm labor or an infection.
The presence of fibronectin means the woman is at risk of having a premature
baby within the next two weeks and needs care to prevent that, said Tokos
Medical Corp. of Santa Ana, Calif., which holds marketing rights to the
test. It was originally developed by Adeza Biomedical Corp. of Sunnyvale,
Calif.
| About the Midwife Archives / Midwife Archives Disclaimer |